Antipyretic drugs :: Consumers survey results of 2016

Consumers survey results of 2016 in category

Cold and Flu / Antipyretic drugs

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	5	Аспірин (Bayer)	18.82%	5

2.	3	Нурофєн (Reckitt Benckiser)	20.00%	4.16

3.	2	Колдрекс (GlaxoSmithKline)	14.12%	3.86

4.	1	Анальгін-Дарниця (Darnitsa)	12.94%	3.425

5.	8	Парацетамол-Дарниця (Darnitsa)	14.12%	3.415

6.	4	Німесил (Berlin-Chemie Menarini)	11.76%	3.321

7.	11	Упсарин Упса (Bristol-Myers Squibb)	10.59%	2.651

8.	9	Ефералган (Bristol-Myers Squibb)	10.59%	2.642

9.	13	Терафлю (Novartis OTC)	10.59%	2.547

10.	14	Панадол (GlaxoSmithKline)	9.41%	2.085

10.	7	Парацетамол (Arterium Corporation)	8.24%	2.085

12.	17	Анальгін (Pharmaceutical company “Zdorovya”)	7.06%	2

13.	19	Antiflu (Bayer)	7.06%	1.849

14.	24	Хелпекс (Movi Health GmbH)	9.41%	1.792

–.	1	~~Ibuprom (EU Pharmacia)~~	~~2.35%~~	~~1.698~~

15.	12	Грипго (Gledpharm)	5.88%	1.670

16.	9	Фармацитрон (Pharmascience)	5.88%	1.481

17.	15	Мілістан (Mili Healthcare)	5.88%	1.340

18.	30	Флюколд-N (Nabros Pharma)	5.88%	1.321

19.	16	Антикатарал (Сперко Україна)	5.88%	1.274

20.	6	Фервекс (Bristol-Myers Squibb)	4.71%	1.245

21.	20	Комбігрип (ORGANOSYN)	4.71%	1.236

22.	20	Ринза (Johnson & Johnson)	5.88%	1.226

23.	17	Аскофен Л (Лубнифарм)	4.71%	1.179

23.	21	Парацетамол (Лубнифарм)	4.71%	1.179

25.	10	Анальгін (Лубнифарм)	3.53%	1.019

26.		Колдакт Флю Плюс (Ranbaxy)	3.53%	0.953

27.	28	Гриппостад (Nizhpharm)	3.53%	0.906

28.	31	Кофальгін (Борщагівський ХФЗ)	4.71%	0.755

29.	20	Цитрамон Форте (Стиролбіофарм)	2.35%	0.708

30.	14	Цитрамон Екстра (Darnitsa)	2.35%	0.623

31.	16	Аскофен-Дарниця (Darnitsa)	2.35%	0.613

31.	28	Фармадол (Farmak)	2.35%	0.613

33.	21	Імет (Berlin-Chemie Menarini)	2.35%	0.566

34.	29	Колдфлю Екстра (Genom Biotech)	2.35%	0.528

35.	14	Грипмакс (Unipharm, Inc)	2.35%	0.472

35.	31	Німегезик (Alembic Chemical Works Company Ltd)	2.35%	0.472

35.	19	Рапідол (Actavis)	2.35%	0.472

38.	22	Цитропак-Дарниця (Darnitsa)	1.18%	0.425

39.	17	Парацетамол (Стиролбіофарм)	2.35%	0.377

39.	29	Парацетамол (сироп) (Борщагівський ХФЗ)	2.35%	0.377

41.	29	Аскопар (Pharmaceutical company “Zdorovya”)	1.18%	0.340

41.	~	Грипаут (Wens Formulation)	1.18%	0.340

41.	18	Грипомед (Red star)	1.18%	0.340

–.		Копацил (Arterium Corporation)	0.00%	0

–.	27	Інсті (Herbion)	0.00%	0

–.	25	Колдрін (Teva)	0.00%	0

–.		Кофан (Bosnalijek)	0.00%	0

–.		Максиган (Unichem Laboratories)	0.00%	0

–.	23	Найз (Nimesulid)	0.00%	0

–.	31	Налгезін (KRKA)	0.00%	0

–.		Пенталгін (Львівтехнофарм)	0.00%	0

–.		Пенталгін IC (InterChem)	0.00%	0

–.		Пенталгін-ICN (Фармстандарт-Лекарства)	0.00%	0

–.		Пенталгін-ФС (Фарма Старт)	0.00%	0

–.		Пиарон (Kusum Pharm)	0.00%	0

–.		Риніколд (Shreya Life Sciences)	0.00%	0

–.		Тринелл (Береш Фарма)	0.00%	0

–.	28	Цефекон Н (Nizhpharm)	0.00%	0

–.		Цитрамон У (Лубнифарм)	0.00%	0

–.		Цитрамон-М (Red star)	0.00%	0

–.	26	Цитрамон-Ф (Фітофарм)	0.00%	0

–.		Viks active (Procter & Gamble)	0.00%	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2016, recommendation of consumers #1 in the category “Antipyretic drugs”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2016, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.